Ohe Y - Search Results

1

A retrospective analysis of patients receiving surgery after chemotherapy for small cell lung cancer.

Yamada K, Saijo N, Kojima A, Ohe Y, Tamura T, Sasaki Y, Eguchi K, Shinkai T, Goya T, Kondou H, et al. Yamada K, et al. Among authors: ohe y. Jpn J Clin Oncol. 1991 Feb;21(1):39-45. Jpn J Clin Oncol. 1991. PMID: 1648633

2

Chemotherapy-induced anemia in patients with primary lung cancer.

Okamoto H, Saijo N, Shinkai T, Eguchi K, Sasaki Y, Tamura T, Ohe Y, Kojima A, Kunikane H, Karato A, et al. Okamoto H, et al. Among authors: ohe y. Ann Oncol. 1992 Dec;3(10):819-24. doi: 10.1093/oxfordjournals.annonc.a058103. Ann Oncol. 1992. PMID: 1286044 Free article. Clinical Trial.

3

[Induction of tumor immunity by cytokine cDNA transfected Lewis lung carcinoma].

Ohira T, Ohe Y, Saijo N. Ohira T, et al. Among authors: ohe y. Nihon Kyobu Shikkan Gakkai Zasshi. 1992 Dec;30 Suppl:48-51. Nihon Kyobu Shikkan Gakkai Zasshi. 1992. PMID: 1306238 Japanese.

4

A prognostic-factor risk index in advanced non-small-cell lung cancer treated with cisplatin-containing combination chemotherapy.

Shinkai T, Eguchi K, Sasaki Y, Tamura T, Ohe Y, Kojima A, Oshita F, Miya T, Okamoto H, Iemura K, et al. Shinkai T, et al. Among authors: ohe y. Cancer Chemother Pharmacol. 1992;30(1):1-6. doi: 10.1007/BF00686477. Cancer Chemother Pharmacol. 1992. PMID: 1316809

5

Mechanisms of collateral sensitivity to fluorouracil of a cis-diamminedichloroplatinum(II)-resistant human non-small lung cancer cell line.

Sugimoto Y, Ohe Y, Nishio K, Ohmori T, Morikage T, Fujiwara Y, Saijo N. Sugimoto Y, et al. Among authors: ohe y. Br J Cancer. 1992 Jun;65(6):857-64. doi: 10.1038/bjc.1992.181. Br J Cancer. 1992. PMID: 1319727 Free PMC article.

6

Phase I study and pharmacokinetics of CPT-11 with 5-day continuous infusion.

Ohe Y, Sasaki Y, Shinkai T, Eguchi K, Tamura T, Kojima A, Kunikane H, Okamoto H, Karato A, Ohmatsu H, et al. Ohe Y, et al. J Natl Cancer Inst. 1992 Jun 17;84(12):972-4. doi: 10.1093/jnci/84.12.972. J Natl Cancer Inst. 1992. PMID: 1321253 Clinical Trial. No abstract available.

7

In vitro enhancement of fluoropyrimidine-induced cytotoxicity by leucovorin in colorectal and gastric carcinoma cell lines but not in non-small-cell lung carcinoma cell lines.

Sugimoto Y, Ohe Y, Nishio K, Ohmori T, Fujiwara Y, Saijo N. Sugimoto Y, et al. Among authors: ohe y. Cancer Chemother Pharmacol. 1992;30(6):417-22. doi: 10.1007/BF00685591. Cancer Chemother Pharmacol. 1992. PMID: 1327567

8

A new 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay for testing macrophage cytotoxicity to L1210 and its drug-resistant cell lines in vitro.

Jiao H, Shen W, Ohe Y, Miura K, Tamura T, Saijo N. Jiao H, et al. Among authors: ohe y. Cancer Immunol Immunother. 1992;35(6):412-6. doi: 10.1007/BF01789020. Cancer Immunol Immunother. 1992. PMID: 1394344 Free PMC article.

9

Differential macrophage-mediated cytotoxicity to P388 leukemia cells and its drug-resistant cells examined by a new MTT assay.

Jiao H, Soejima Y, Ohe Y, Miura K, Tamura T, Saijo N. Jiao H, et al. Among authors: ohe y. Leuk Res. 1992 Dec;16(12):1175-80. doi: 10.1016/0145-2126(92)90115-n. Leuk Res. 1992. PMID: 1465025

10

A new MTT assay for examining the cytotoxicity of activated macrophages towards the non-adherent P388 leukaemia cell line.

Jiao H, Soejima Y, Ohe Y, Saijo N. Jiao H, et al. Among authors: ohe y. J Immunol Methods. 1992 Aug 30;153(1-2):265-6. doi: 10.1016/0022-1759(92)90331-m. J Immunol Methods. 1992. PMID: 1517599 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

722 results

Search Page

Filters